Literature DB >> 20227645

Sciatica.

Jean-Pierre Valat1, Stéphane Genevay, Marc Marty, Sylvie Rozenberg, Bart Koes.   

Abstract

Sciatica is a symptom rather than a specific diagnosis. Available evidence from basic science and clinical research indicates that both inflammation and compression are important in order for the nerve root to be symptomatic. Tumour necrosis factor-alpha (TNF-alpha) is a key mediator in animal models, but its exact contribution in human radiculopathy is still a matter of debate. Sciatica is mainly diagnosed by history taking and physical examination. In general, the clinical course of acute sciatica is considered to be favourable. In the first 6-8 weeks, there is consensus that treatment of sciatica should be conservative. We review and comment on the levels of evidence of the efficacy of patient information, advice to stay active, physical therapy analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), epidural corticosteroid injections and transforaminal peri-radicular injections of corticosteroid. There is good evidence that discectomy is effective in the short term. but, in the long term, it is not more effective than prolonged conservative care. Shared decision making with regard to surgery is necessary in the absence of severe progressive neurological symptoms. Although the term sciatica is simple and easy to use, it is, in fact, an archaic and confusing term. For most researchers and clinicians, it refers to a radiculopathy, involving one of the lower extremities, and related to disc herniation (DH). As such, the term 'sciatica' is too restrictive as nerve roots from L1 to L4 may also be involved in the same process. However, even more confusing is the fact that patients, and many clinicians alike, use sciatica to describe any pain arising from the lower back and radiating down to the leg. The majority of the time, this painful sensation is referred pain from the lower back and is neither related to DH nor does it result from nerve-root compression. Although differentiating the radicular pain from the referred pain may be challenging for the clinician, it is of primary importance. This is because the epidemiology, clinical course and, most importantly, therapeutic interventions are different for these two conditions. It should, however, be emphasised that the quality of the available evidence is rather limited due to a considerable heterogeneity in the study populations included in the trials. This makes generalisation of findings across studies, and to routine clinical practice, a challenge. Prevalence estimates of radicular pain related to DH also vary considerably between studies, which is, in part, due to differences in the definitions used. A recent review showed that the prevalence of sciatic symptoms is rather variable, with values ranging from 1.6% to 43%. If stricter definitions of sciatica were used, for example, in terms of pain distribution and/or pain duration, lower prevalence rates were reported. Studies in working populations with physically demanding jobs consistently report higher rates of sciatica compared with studies in the general population. Copyright 2009. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20227645     DOI: 10.1016/j.berh.2009.11.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  74 in total

Review 1.  Epidural steroid injections.

Authors:  Indy M Wilkinson; Steven P Cohen
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Pragmatic neural tissue management improves short-term pain and disability in patients with sciatica: a single-arm clinical trial.

Authors:  Renato Santos de Almeida; Eduardo Machado; Tiê Parma Yamato; Luciano Santos De Melo; Leandro Alberto Calazans Nogueira
Journal:  J Man Manip Ther       Date:  2019-02-26

Review 3.  Systematic review of microendoscopic discectomy for lumbar disc herniation.

Authors:  Nick Smith; James Masters; Cyrus Jensen; Almas Khan; Andrew Sprowson
Journal:  Eur Spine J       Date:  2013-06-23       Impact factor: 3.134

Review 4.  Epidural steroid compared to placebo injection in sciatica: a systematic review and meta-analysis.

Authors:  E J A Verheijen; C A Bonke; E M J Amorij; C L A Vleggeert-Lankamp
Journal:  Eur Spine J       Date:  2021-05-11       Impact factor: 3.134

5.  A meta-analysis of endoscopic discectomy versus open discectomy for symptomatic lumbar disk herniation.

Authors:  Lin Cong; Yue Zhu; Guanjun Tu
Journal:  Eur Spine J       Date:  2015-01-30       Impact factor: 3.134

6.  Prognostic factors of sciatica in the Canon of Avicenna.

Authors:  Bagher Minaee; Alireza Abbassian; Alireza Nikbakht Nasrabadi; Abdorrahman Rostamian
Journal:  Rheumatol Int       Date:  2012-11-15       Impact factor: 2.631

Review 7.  Do Epidural Injections Provide Short- and Long-term Relief for Lumbar Disc Herniation? A Systematic Review.

Authors:  Laxmaiah Manchikanti; Ramsin M Benyamin; Frank J E Falco; Alan D Kaye; Joshua A Hirsch
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

8.  Influence of preoperative leg pain and radiculopathy on outcomes in mono-segmental lumbar total disc replacement: results from a nationwide registry.

Authors:  Thomas Zweig; Emin Aghayev; Markus Melloh; Daniel Dietrich; Christoph Röder
Journal:  Eur Spine J       Date:  2011-06-10       Impact factor: 3.134

9.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

Review 10.  Surgery or physical activity in the management of sciatica: a systematic review and meta-analysis.

Authors:  Matthew Fernandez; Manuela L Ferreira; Kathryn M Refshauge; Jan Hartvigsen; Isabela R C Silva; Chris G Maher; Bart W Koes; Paulo H Ferreira
Journal:  Eur Spine J       Date:  2015-07-26       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.